These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 17121527

  • 1. Increased plasma concentrations of N-terminal pro-B-type natriuretic peptide in patients with mild primary hyperparathyroidism.
    Almqvist EG, Becker C, Bondeson AG, Bondeson L, Svensson J, Svensson SE.
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):760-6. PubMed ID: 17121527
    [Abstract] [Full Text] [Related]

  • 2. Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism.
    Ogard CG, Engelmann MD, Kistorp C, Nielsen SL, Vestergaard H.
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):493-8. PubMed ID: 16268799
    [Abstract] [Full Text] [Related]

  • 3. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction.
    Campbell DJ, Mitchelhill KI, Schlicht SM, Booth RJ.
    J Card Fail; 2000 Jun; 6(2):130-9. PubMed ID: 10908087
    [Abstract] [Full Text] [Related]

  • 4. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M, Bozkurt A, Yildiray-Sahin D, Unal I, Acartürk E.
    Cardiol J; 2009 Jun; 16(1):43-9. PubMed ID: 19130415
    [Abstract] [Full Text] [Related]

  • 5. Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism.
    Almqvist EG, Bondeson AG, Bondeson L, Svensson J.
    Scand J Clin Lab Invest; 2011 Apr; 71(2):139-44. PubMed ID: 21166606
    [Abstract] [Full Text] [Related]

  • 6. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
    Rothenburger M, Stypmann J, Bruch C, Wichter T, Hoppe M, Drees G, Berendes E, Huelsken G, Loeher A, Welp H, Röttger C, Schmid C, Scheld HH, Tjan TD.
    J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
    [Abstract] [Full Text] [Related]

  • 7. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D, Matias JS, Sargento L, Cabral MJ, Madeira HC.
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S, Kümpers P, Seidler V, Biertz F, Haller H, Fliser D.
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [Abstract] [Full Text] [Related]

  • 9. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G, Runkel S, Zdunek D, Hitzler WE.
    Clin Lab; 2005 Apr; 51(3-4):167-72. PubMed ID: 15819172
    [Abstract] [Full Text] [Related]

  • 10. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements.
    Tschöpe C, Kasner M, Westermann D, Gaub R, Poller WC, Schultheiss HP.
    Eur Heart J; 2005 Nov; 26(21):2277-84. PubMed ID: 16014646
    [Abstract] [Full Text] [Related]

  • 11. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M.
    Int J Cardiol; 2008 Aug 18; 128(2):244-9. PubMed ID: 17673312
    [Abstract] [Full Text] [Related]

  • 12. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 13. NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study.
    Krittayaphong R, Boonyasirinant T, Saiviroonporn P, Udompunturak S.
    Coron Artery Dis; 2008 Nov 13; 19(7):481-7. PubMed ID: 18923244
    [Abstract] [Full Text] [Related]

  • 14. Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy.
    Tang WH, Steinhubl SR, Van Lente F, Brennan D, McErlean E, Maroo A, Francis GS, Topol EJ.
    Am Heart J; 2007 Jan 13; 153(1):36-41. PubMed ID: 17174634
    [Abstract] [Full Text] [Related]

  • 15. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR, Zhang YH, Xu Q, Qiu HX, Chen Q.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun 13; 11(6):429-32. PubMed ID: 19558803
    [Abstract] [Full Text] [Related]

  • 16. [Changes of serum N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases and its clinical significance].
    Yang CL, Qiu YR, Zhou F, Feng PF.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May 13; 28(5):866-9. PubMed ID: 18504223
    [Abstract] [Full Text] [Related]

  • 17. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV.
    J Heart Lung Transplant; 2007 May 13; 26(5):516-21. PubMed ID: 17449423
    [Abstract] [Full Text] [Related]

  • 18. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit.
    Forfia PR, Watkins SP, Rame JE, Stewart KJ, Shapiro EP.
    J Am Coll Cardiol; 2005 May 17; 45(10):1667-71. PubMed ID: 15893185
    [Abstract] [Full Text] [Related]

  • 19. Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study.
    Chang AY, Abdullah SM, Jain T, Stanek HG, Das SR, McGuire DK, Auchus RJ, de Lemos JA.
    J Am Coll Cardiol; 2007 Jan 02; 49(1):109-16. PubMed ID: 17207730
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.
    Am J Cardiol; 2008 Sep 15; 102(6):733-7. PubMed ID: 18773998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.